Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review
Edward Willow, Aditi Chaudhri, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H Dworkin · 2026
Read Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review by Edward Willow, Aditi Chaudhri, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H Dworkin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13354651.txt.
Description
Edward Willow and co-authors reviewed studies in 2026 on dextromethorphan, a common cough drug sold without a prescription in the United States. At high doses the drug can cause psychedelic-like effects, which has raised interest in it for hard-to-treat mental illness. The review asks what doses cause which effects, and how safe those doses are.
Only eight studies, with 104 people in total, met the review rules. Effects began near 100 mg, while nausea, slow thinking, and trouble moving grew above 200 mg, and stronger visions came at higher doses. The authors say the proof is too thin to set a safe dose range, so larger dose-finding studies are needed.
Catalog record
| CREATOR | Edward Willow, Aditi Chaudhri, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H Dworkin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42517 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |